Introducing L’AuRa – the result of diligent discovery, state of the art nano-science and a collaborative team penchant for uncompromising precision

Technology Platform for Quantitative, Ultra-Sensitive and Rapid Diagnostics MENLO PARK, CA, October 26, 2016 – LamdaGen Corporation, a leading developer of diagnostic biosensors, introduced the L’AuRa digital platform to meet the requirements of decentralized, patient-centric mobile testing while delivering precision, Continue reading